Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
07/31/2017
A study presented at the 2017 EULAR Congress showed that using two measurements can accurately predict relapse risk among RA, allowing physicians to adjust dosing of disease-modifying antirheumatic drugs (DMARDs). This new prediction tool...
A study presented at the 2017 EULAR Congress showed that using two measurements can accurately predict relapse risk among RA, allowing physicians to adjust dosing of disease-modifying antirheumatic drugs (DMARDs). This new prediction tool...
A study presented at the 2017...
07/31/2017
First Report Managed Care
News Connection
07/31/2017
After more than a month of tight-lipped deliberations, Senate Republicans finally unveiled their revised version of the American Health Care Act (AHCA)—known as the Better Care Reconciliation Act (BCRA), which will repeal many aspects of the...
After more than a month of tight-lipped deliberations, Senate Republicans finally unveiled their revised version of the American Health Care Act (AHCA)—known as the Better Care Reconciliation Act (BCRA), which will repeal many aspects of the...
After more than a month of...
07/31/2017
First Report Managed Care

Advertisement

Formulary Frontlines®
07/23/2017
Michael Greenwood, MD, associate medical director of Dakota Sight at Vance Thompson Vision, discusses the wide variety of glaucoma treatments on the market, how to choose the best treatment. 
Michael Greenwood, MD, associate medical director of Dakota Sight at Vance Thompson Vision, discusses the wide variety of glaucoma treatments on the market, how to choose the best treatment. 
Michael Greenwood, MD, associate...
07/23/2017
First Report Managed Care
Conference Insider
07/06/2017
Gary Owens, MD, a managed health care consultant and a First Report Managed Care Editorial Advisory Board member, presented “Improving Patient Outcomes with Novel Treatments and Strategies in the Management of Relapsing Multiple Sclerosis,”...
Gary Owens, MD, a managed health care consultant and a First Report Managed Care Editorial Advisory Board member, presented “Improving Patient Outcomes with Novel Treatments and Strategies in the Management of Relapsing Multiple Sclerosis,”...
Gary Owens, MD, a managed health...
07/06/2017
First Report Managed Care
Conference Insider
07/06/2017
Steven R Feldman, MD, PhD, professor of dermatology at the Psoriasis Treatment Center at Wake Forest University School of Medicine, discussed how to improve treatment adherence and outcomes in patients with psoriasis at the NAMCP 2017 Spring...
Steven R Feldman, MD, PhD, professor of dermatology at the Psoriasis Treatment Center at Wake Forest University School of Medicine, discussed how to improve treatment adherence and outcomes in patients with psoriasis at the NAMCP 2017 Spring...
Steven R Feldman, MD, PhD,...
07/06/2017
First Report Managed Care

Advertisement

Conference Insider
07/06/2017
A quality improvement initiative using fecal immunochemical testing (FIT) and colonoscopy was able to improve colorectal cancer (CRC) screening uptake in a managed care setting, according to a poster presented at Digestive Disease Week 2017.
A quality improvement initiative using fecal immunochemical testing (FIT) and colonoscopy was able to improve colorectal cancer (CRC) screening uptake in a managed care setting, according to a poster presented at Digestive Disease Week 2017.
A quality improvement initiative...
07/06/2017
First Report Managed Care
Conference Insider
07/06/2017
Research presented at Digestive Disease Week 2017 found that switching from Remicade (infliximab; Janssen) to Inflectra (infliximab-dyyb; Pfizer) did not cause inflammatory bowel disease (IBD) symptoms to evolve among a patient cohort in...
Research presented at Digestive Disease Week 2017 found that switching from Remicade (infliximab; Janssen) to Inflectra (infliximab-dyyb; Pfizer) did not cause inflammatory bowel disease (IBD) symptoms to evolve among a patient cohort in...
Research presented at Digestive...
07/06/2017
First Report Managed Care
Conference Insider
07/06/2017
A recent presentation at Digestive Disease Week 2017 showed that integrated models of care improve management and outcomes of inflammatory bowel diseases like Crohn disease and ulcerative colitis.
A recent presentation at Digestive Disease Week 2017 showed that integrated models of care improve management and outcomes of inflammatory bowel diseases like Crohn disease and ulcerative colitis.
A recent presentation at...
07/06/2017
First Report Managed Care

Advertisement

Conference Insider
07/06/2017
Recent research from two phase 3 clinical trials, presented at Digestive Disease Week 2017, showed that Trulance (plecanatide; Synergy) is safe and effective at reducing symptom severity in patients with irritable bowel syndrome (IBS) with...
Recent research from two phase 3 clinical trials, presented at Digestive Disease Week 2017, showed that Trulance (plecanatide; Synergy) is safe and effective at reducing symptom severity in patients with irritable bowel syndrome (IBS) with...
Recent research from two phase 3...
07/06/2017
First Report Managed Care
Conference Insider
07/06/2017
A study presented at Digestive Disease Week 2017 found that nonsurgical endoscopic sleeve gastroplasty may be an effective option for treating obesity in patients who are not candidates for surgery. 
A study presented at Digestive Disease Week 2017 found that nonsurgical endoscopic sleeve gastroplasty may be an effective option for treating obesity in patients who are not candidates for surgery. 
A study presented at Digestive...
07/06/2017
First Report Managed Care

Advertisement